N-[(furan-2-yl)methyl]-3-methyl-N-[2-(morpholin-4-yl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide
Chemical Structure Depiction of
N-[(furan-2-yl)methyl]-3-methyl-N-[2-(morpholin-4-yl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide
N-[(furan-2-yl)methyl]-3-methyl-N-[2-(morpholin-4-yl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide
Compound characteristics
Compound ID: | G008-3402 |
Compound Name: | N-[(furan-2-yl)methyl]-3-methyl-N-[2-(morpholin-4-yl)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-7-sulfonamide |
Molecular Weight: | 465.59 |
Molecular Formula: | C21 H27 N3 O5 S2 |
Smiles: | CC1CSc2ccc(cc2NC1=O)S(N(CCN1CCOCC1)Cc1ccco1)(=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 2.2719 |
logD: | 2.2649 |
logSw: | -2.9706 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 76.169 |
InChI Key: | LDDCUEOJUMXZNS-MRXNPFEDSA-N |